In agreement with this latter result, both genetic and pharmacological manipulations aimed at inducing HO-1 expression protected mice against EAE [4], autoimmune type 1 diabetes (T1D) [5,6], and allergic asthma [7]. This evidence concerns the gene HMOX1 and type 1 diabetes mellitus.